InsideScientific | A Scientist.com Company’s Post

Explore the advanced applications of Nucleosome Quantification (Nu.Q®) technology for drug development and disease monitoring! This session features leading experts in epigenetics and assay development – Eric A. Ariazi, PhD, and Terry Kelly, PhD. Presentations will focus on the critical role of nucleosome-based markers in accelerating oncology clinical trials and enhancing drug efficacy and safety monitoring. Learn more & register here: https://bit.ly/3vLcdkX Key topics will include: ☑️ Next-generation epigenetic immunoassay for quantitative assessment of circulating nucleosomes ☑️ The role of Histone PTMs as biomarkers for chromatin-targeted therapies ☑️ Liquid biopsy applications in precision oncology ☑️ Expanding the utility of circulating nucleosomes to predict adverse reactions in therapy, including CAR-T cell treatment Thank you to Volition for making this webinar possible! #Immunoassay #Epigenetics #Genetherapy

  • No alternative text description for this image

To view or add a comment, sign in

Explore topics